Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07818720 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

MLS101 Study in PMDD

StatusNot Yet Recruiting
PhasePhase 1
Started
View on ClinicalTrials.gov ↗

Record History

  1. Study First Submitted
The goal of this clinical trial is to learn if MLS101 (psilocybin) is a possible treatment for women with Premenstrual Dysphoric Disorder (PMDD). The main question it aims to answer is: • Test the safety and tolerability of the study drug, MLS101 in premenopausal women (ages 18-50 inclusive) with PMDD.
Trial Details
NCT Number NCT07818720
Lead Sponsor MycoMedica Life Sciences PBC
Conditions
(from sponsor)		 Premenstrual Dysphoric Disorder ( PMDD), PMDD
Related terms Premenstrual Dysphoric Disorder
Enrollment 32 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov